Construction work on Lendava Biosimilars Production Plant located in Slovenia commenced in Q4 2023, after the project was announced in Q2 2021. According to GlobalData, who tracks and profiles more than 220,000 major construction projects from announcement to completion, the project is expected to be completed by Q4 2026. To learn more about the Lendava Biosimilars Production Plant project, buy the profile here.
The project involves the construction of a 40,000m2 biosimilars production plant in Lendava, Prekmurje, Slovenia.
Smarter leaders trust GlobalData
The project includes the following:
1. Construction of a manufacturing unit
2. Construction of a packing unit
3. Construction of storage facilities
4. Construction of laboratories
5. Installation of equipment
6. Construction of related infrastructure
Construction on the project is expected to be completed by Q4 2026.
For more details on the Lendava Biosimilars Production Plant project, buy the profile here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying research used to produce this article.
GlobalData’s Construction Projects database tracks over 220,000 new construction projects valued at >$25m from announcement to completion across all countries and sectors.
